LIC MF Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • (-0.03%)Nav, as on 30-04-2025

  • Previous Nav

  • Net Change on 30-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
LIC MF Healthcare Fund-Direct Plan-Growth -0.78 -1.14 17.75 17.40 18.76 19.81
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
LIC MF Healthcare Fund-Direct Plan-Growth Feb 28, 2019 17.75 17.40 18.76 1.22 82.69
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 17.02 21.10 23.67 0.91 8,080.97
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 22.56 25.31 26.43 1.18 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 22.51 25.11 26.02 0.90 3,610.51
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 15.60 21.29 25.69 0.63 3,018.76
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 19.34 20.18 24.26 0.61 2,667.40

Fund Holdings as on 31-March-2025

  • Sun Pharmaceutical Industries Ltd.

  • Piramal Pharma Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Artemis Medicare Services Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Cipla Ltd.

  • Divi's Laboratories Ltd.

  • Alkem Laboratories Ltd.

  • Abbott India Ltd.

  • Syngene International Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Global Health Ltd.

  • Navin Fluorine International Ltd.

  • IPCA Laboratories Ltd.

  • Dr Agarwal's Health Care Ltd.

  • Neuland Laboratories Ltd.

  • Onesource Specialty Pharma Ltd.

  • Mankind Pharma Ltd.

  • Aurobindo Pharma Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Treps

  • Vinati Organics Ltd.

  • Zydus Lifesciences Ltd.

  • Concord Biotech Ltd.

  • Metropolis Healthcare Ltd.

  • Laurus Labs Ltd.

  • Suven Pharmaceuticals Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Business Support

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About LIC MF Healthcare Fund

Scheme Analysis

LIC MF Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to LIC Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹82.69 crore. LIC MF Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of LIC MF Healthcare Fund ended down ₹-0.01(-0.03%)yesterday to ₹30.5103.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The LIC MF Healthcare Fund is managed by Karan Doshi .

Fund House Contact

4th Floor, Industrial Assurance Building, Opp. Churchgate Station, Mumbai - 400 020

022-66016000
service@licnomuramf.com
022-22880633